MeiraGTx Holdings PLC (MGTX)

Industry Biotechnology


This stock can be held in an Investment ISA and an Investment Account
Sell

$9.04

Buy

$9.70

arrow-up$0.09 (+0.99%)

Prices updated at 02 Apr 2026, 22:23 EDT
| Prices minimum 15 mins delay
|
Prices in USD

MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Keith R. Harris, PhD
CEO
Dr. Alexandria Forbes, PhD
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
403
Head office
655 Third Avenue
New York
United States
10017
mobile
+1 646 860-7985
letter
-

Key personnel

Salary
Dr. Thomas E. Shenk, PhD
Independent Director
0.09m
Ms. Nicole Seligman
Independent Director
0.10m
Dr. Alexandria Forbes, PhD
President, Chief Executive Officer and Director
0.84m
Mr. Richard Giroux
Chief Accounting Officer, Chief Operating Officer and Chief Financial Officer
0.71m
Dr. Keith R. Harris, PhD
Chairman of the Board
0.16m
Dr. Ellen Hukkelhoven, PhD
Director
-
Lord Neil Mendoza
Independent Director
0.10m
Dr. Debra Yu, M.D.
Independent Director
0.08m
Dr. Stuart Naylor, PhD
Chief Development Officer
0.50m
Dr. Robert K. Zeldin, M.D.
Chief Medical Officer
-
Mr. Robert J. Wollin
General Counsel and Secretary
-

Top 5 shareholders

No. of shares
Perceptive Advisors LLC12,626,103
Sanofi12,197,737
Johnson & Johnson6,641,064
Rubric Capital Management LP6,175,331
Adage Capital Partners Gp LLC4,000,000

Director dealings

Action
23 Dec 2025-
20 Nov 2025-
21 Oct 2025-
07 Oct 2025-
22 Jul 2025-
08 Jul 2025-
30 Jun 2025-
12 Jun 2025-
12 Jun 2025-
12 Jun 2025-
12 Jun 2025-
12 Jun 2025-
12 Jun 2025-
06 Jun 2025-
06 Jun 2025-
22 Apr 2025-
08 Apr 2025-
03 Apr 2025-
03 Apr 2025-
03 Apr 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.